Breast cancer in Belgium : why are we the first in Europe?
Breast cancer incidence in Belgium is on the top of European countries, with 9.697 new cases in 2008 and 106/100.000 women/year. The explanation of this high incidence in our country is probably the accumulation of risk factors (many of them are linked to lifestyle), and the impact of screening and registration of cases. The relative impact of each of theses factors is less clear because we don't have powerful statistical studies. Belgium is slightly above the European mean for breast cancer mortality, with 19,4/100.000 women/year and an all stages 15-year survival of 75%. Breast cancers are responsible for around 3% of all-cause mortality in Belgian women. This article discusses the causes of this high Belgian incidence and of current decrease of incidence in western countries, and reviews known and less known risk factors of breast cancers, with a special focus on menopause hormonal treatments.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
---|---|
Enthalten in: |
Revue medicale de Liege - 66(2011), 5-6 vom: 30. Mai, Seite 231-7 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Le cancer du sein en Belgique: pourquoi sommes-nous les premiers en Europe? |
---|
Beteiligte Personen: |
Desreux, J [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 27.09.2011 Date Revised 26.08.2015 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM210610522 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM210610522 | ||
003 | DE-627 | ||
005 | 20231224011957.0 | ||
007 | tu | ||
008 | 231224s2011 xx ||||| 00| ||fre c | ||
028 | 5 | 2 | |a pubmed24n0702.xml |
035 | |a (DE-627)NLM210610522 | ||
035 | |a (NLM)21826953 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Desreux, J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Breast cancer in Belgium |b why are we the first in Europe? |
246 | 3 | 3 | |a Le cancer du sein en Belgique: pourquoi sommes-nous les premiers en Europe? |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 27.09.2011 | ||
500 | |a Date Revised 26.08.2015 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Breast cancer incidence in Belgium is on the top of European countries, with 9.697 new cases in 2008 and 106/100.000 women/year. The explanation of this high incidence in our country is probably the accumulation of risk factors (many of them are linked to lifestyle), and the impact of screening and registration of cases. The relative impact of each of theses factors is less clear because we don't have powerful statistical studies. Belgium is slightly above the European mean for breast cancer mortality, with 19,4/100.000 women/year and an all stages 15-year survival of 75%. Breast cancers are responsible for around 3% of all-cause mortality in Belgian women. This article discusses the causes of this high Belgian incidence and of current decrease of incidence in western countries, and reviews known and less known risk factors of breast cancers, with a special focus on menopause hormonal treatments | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Gaspard, U |e verfasserin |4 aut | |
700 | 1 | |a Bleret, V |e verfasserin |4 aut | |
700 | 1 | |a Van Cauwenberge, J-R |e verfasserin |4 aut | |
700 | 1 | |a Thille, A |e verfasserin |4 aut | |
700 | 1 | |a Herman, P |e verfasserin |4 aut | |
700 | 1 | |a Lifrange, E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revue medicale de Liege |d 1947 |g 66(2011), 5-6 vom: 30. Mai, Seite 231-7 |w (DE-627)NLM000044490 |x 0370-629X |7 nnns |
773 | 1 | 8 | |g volume:66 |g year:2011 |g number:5-6 |g day:30 |g month:05 |g pages:231-7 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 66 |j 2011 |e 5-6 |b 30 |c 05 |h 231-7 |